Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.

Item
http://www.wikidata.org/entity/Q37040692
Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy.Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents.Recent aspects of sunitinib therapy in patients with metastatic clear-cell renal cell carcinoma: a systematic review of the literature.Optimal treatment of poor-risk renal cell carcinoma patients with mTOR inhibitors and anti-VEGFR agents.Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees.Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions.Sunitinib Possible Sex-Divergent Therapeutic Outcomes.Modeling and simulations relating overall survival to tumor growth inhibition in renal cell carcinoma patients.Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States.Mitochondrial ASncmtRNA-1 and ASncmtRNA-2 as potent targets to inhibit tumor growth and metastasis in the RenCa murine renal adenocarcinoma model.Effects of local irradiation combined with sunitinib on early remodeling, mitochondria, and oxidative stress in the rat heartReal-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib.Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice.Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice.Sunitinib DDI with paracetamol, diclofenac, mefenamic acid and ibuprofen shows sex-divergent effects on the tissue uptake and distribution pattern of sunitinib in mice.An update on current management of advanced renal cell cancer, biomarkers, and future directions
P2860

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.

Item
http://www.wikidata.org/entity/Q37040692
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development and validation of ...... nib: a European collaboration.
@en
Development and validation of ...... nib: a European collaboration.
@nl
type
label
Development and validation of ...... nib: a European collaboration.
@en
Development and validation of ...... nib: a European collaboration.
@nl
prefLabel
Development and validation of ...... nib: a European collaboration.
@en
Development and validation of ...... nib: a European collaboration.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Development and validation of ...... nib: a European collaboration.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932